Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-24

Clinical Trial Update: Clinical Experience of Thalidomide in Thalassemic Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting experience with thalidomide in thalassemia patients (Phase 2 and Phase 3; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Children's Hospital Karachi | Conditions: Thalassemia, Beta | Phase 2, Phase 3 | Status: COMPLETED